Enhancing stability of implants using two different techniques

Clinical and Patient based evaluation of the cumulative effect of Platelet Rich Fibrin and Low Level Laser Therapy on implant osseointegration in the Posterior Maxilla - A Split Mouth Randomized Controlled Trial

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/09/009778

Enrollment

Registered

2017-09-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Platelet Rich Fibrin and Low Level Laser Therapy: 10 ml of blood to be withdrawn from each patient. Control Intervention1: Platelet Rich Fibrin only: 10 ml of blood to be withdrawn from

Eligibility

Inclusion criteria

Inclusion criteria: 1. Bilateral edentulous area in the maxillary arch with one or more missing teeth per quadrant 2. Age - 45 Â± 15 years 3. Extraction performed 6 months prior to the implant placement. 4. Adequate amount of bone volume.

Exclusion criteria

Exclusion criteria: 1. Inadequate bone height and bone width 2. Poor oral hygiene 3. Smoking cigarettes >10 per day 4. Systemic diseases affecting osseointegration 5. Para-functional habits

Design outcomes

Primary

Measure	Time frame
LLLT would act as an adjunct to PRF to initiate early bone healing and accelerate osseointegration in low-density bone.Timepoint: T1: immediately after implant placement T2: 1 week after implant placement T3: 1 month after implant placement T4: 3 months after implant placement	—

Secondary

Measure	Time frame
Bone quality is a crucial factor for the success of osseointegrated implants. However, with regard to the rehabilitation of low-density bone, seen often in posterior maxilla, the success rates are not promising.The artificial membranes used to enhance the osseointegration are generally expensive with a possibility of disease transmission; nevertheless, a product from the patientâ??s own blood such as Platelet Rich Fibrin (PRF) would act as a supplement to the procedure of tissue regeneration.Timepoint: T1: immediately after implant placement T2: 1 week after implant placement T3: 1 month after implant placement T4: 3 months after implant placement	—

Measure

Time frame

Bone quality is a crucial factor for the success of osseointegrated implants. However, with regard to the rehabilitation of low-density bone, seen often in posterior maxilla, the success rates are not promising.The artificial membranes used to enhance the osseointegration are generally expensive with a possibility of disease transmission; nevertheless, a product from the patientâ??s own blood such as Platelet Rich Fibrin (PRF) would act as a supplement to the procedure of tissue regeneration.Timepoint: T1: immediately after implant placement T2: 1 week after implant placement T3: 1 month after implant placement T4: 3 months after implant placement

—

Countries

India

Contacts

Public ContactDr Aparna I N

Manipal College of Dental Sciences, Manipal, Karnataka

aparnaaniraghu@gmail.com9845648763

Outcome results